USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke ENCORSTAT wurde als Wortmarke am 24.06.2009 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 04.09.2012 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".
| Markenform | Wortmarke |
| Aktenzeichen | 77767425 |
| Registernummer | 4200422 |
| Anmeldedatum | 24. Juni 2009 |
| Veröffentlichungsdatum | 29. November 2011 |
| Eintragungsdatum | 04. September 2012 |
Markeninhaber
Windrush Court
Oxford OX4 6LT
GB
Oxford OX4 6LT
GB
Markenvertreter
Waren und Dienstleistungen
1
Enzymes for scientific and research purposes in connection with treatment of the eye; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories in connection with treatment for the eye; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research in connection with treatment for the eye; chemical reagents for use in medical science
5
Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic / angiogenic molecules, all for medical purposes in connection with the treatment of diseases of the eye; nucleic acid sequences and chemical reagents for medical purposes in connection with the treatment of diseases of the eye, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations in connection with the treatment of diseases of the eye
10
Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances in connection with the treatment of diseases of the eye; syringes and injectors for medical purposes in connection with the treatment of diseases of the eye
42
Scientific and medical research and development in connection with the treatment of diseases of the eye; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology in connection with the treatment of diseases of the eye; advisory services relating to research and development of gene therapy products all in connection with the treatment of diseases of the eye and specifically excluding analysis services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1377767425